The short answer
Understanding your diagnosis, treatment path, or caregiving steps helps reduce panic and prepares you for productive medical discussions.
Every cancer diagnosis and care plan is customized to an individual's specific health profile.
Having clear medical facts helps patients and families navigate stressful moments.
Communicating openly with healthcare providers ensures timely support and clarity.
Choose how you want to understand this
The full explanation.
Cold Caps & Scalp Cooling to Reduce Hair Loss
Scalp cooling is real, it is regulated, and it works for some people some of the time. It is not a guarantee, and the honest answer to "will this save my hair?" depends heavily on which chemotherapy you are getting.
How it works
A cold cap chills your scalp before, during, and after a chemotherapy infusion. The cold makes blood vessels in the scalp constrict, so less chemotherapy reaches the hair follicles. Cooling also slows follicle activity and cell division, which makes the follicles less vulnerable to drugs that target rapidly dividing cells.
The FDA describes the DigniCap Cooling System as computer-controlled: cooled liquid circulates through a cap worn tightly on the head, covered by a neoprene insulating layer. The National Cancer Institute notes that the idea is not new — in the 1970s, clinicians used ice packs, and some manual cap systems still require the caps to be swapped out repeatedly during a session.
What the FDA has actually cleared
This is the concrete, citable part.
- DigniCap Cooling System (Dignitana Inc.) was cleared by the FDA in 2015 for patients with breast cancer.
- In 2017 the FDA expanded that clearance to "reduce the frequency and severity of hair loss during chemotherapy in solid tumor cancer patients" where chemotherapy that causes hair loss is used. This was the first cooling cap cleared beyond breast cancer.
- The Paxman Scalp Cooler (Paxman Coolers Limited) was cleared on June 7, 2018, "to reduce the likelihood of chemotherapy-induced alopecia (CIA) in cancer patients with solid tumors."
Note what these clearances have in common: solid tumors. Scalp cooling has not been cleared for blood cancers such as leukemia and lymphoma.
How well does it work
The numbers below come from the trials the FDA and NCI cite. They are not promises.
In the original DigniCap study of 122 patients with stage I–II breast cancer, the FDA reports that "more than 66 percent of patients treated with the DigniCap reported losing less than half their hair." NCI's account of that trial adds detail: among 101 patients who used cooling, 4% had no hair loss and 61.4% lost less than half their hair, while all 16 patients in the control group lost more than half. A separate 226-patient trial found 65% had no or mild hair loss, and only 28% needed a wig.
For the Paxman system, NCI reports a study in which all 47 women in the control group lost more than half their hair, compared with 5% of the cooling group who lost none and 45% who lost less than half.
The regimen matters enormously. NCI states that effectiveness depends on the chemotherapy regimen, and that anthracycline-based treatments were less responsive to scalp cooling. The DigniCap trial above enrolled patients on non-anthracycline regimens. If you are on an anthracycline, the odds are less favorable — ask your oncologist how your specific drugs compare.
Dr. Hershman, quoted by NCI, put the limit plainly: "Scalp cooling is not 100% effective," and it should not be offered during chemotherapy regimens that continue indefinitely.
Side effects and who should not use it
The FDA lists cold-induced headaches, neck and shoulder discomfort, chills, and pain from wearing the cap for long periods.
The FDA states DigniCap is contraindicated for pediatric patients, for patients with certain cancers, and for patients receiving certain chemotherapy treatments. It is not recommended for people with cold sensitivity or susceptibility to cold-related injury.
The scalp metastasis question
You may hear a concern that cooling the scalp could shield cancer cells hiding there from chemotherapy. Here is where the two sources sit slightly differently, and both are worth knowing.
The FDA notes a rare risk of chemotherapy missing isolated cancer cells in the scalp, and states directly: "Long-term effects of scalp-cooling and risk of scalp metastasis have not been fully studied."
NCI reports that there is no evidence scalp cooling leads to more scalp metastases, a conclusion supported by recent reviews.
In plain terms: no study has found harm, and the long-term data are still thin. Both statements are true at once.
Cost
NCI reported an average total cost of roughly $1,500 to $3,000 per patient, and that insurance did not cover scalp cooling. Coverage can change, so confirm current pricing and any coverage or grant programs with your treatment center rather than relying on that figure alone.
Sources
- U.S. Food and Drug Administration — FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy: https://www.fda.gov/news-events/press-announcements/fda-clears-expanded-use-cooling-cap-reduce-hair-loss-during-chemotherapy
- FDA 510(k) clearance K173032 — Paxman Scalp Cooler (June 7, 2018): https://www.accessdata.fda.gov/cdrh_docs/pdf17/k173032.pdf
- National Cancer Institute — Cooling Cap to Reduce Chemotherapy-Related Hair Loss: https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-cooling-cap-chemotherapy
<script type="application/ld+json"> { "@context": "https://schema.org", "@type": "MedicalWebPage", "headline": "Cold Caps & Scalp Cooling to Reduce Hair Loss", "description": "An evidence-based guide offering plain-language medical information and patient navigation.", "url": "https://cancerexplained.org/side-effects/cold-caps-and-whether-they-reduce-hair-loss", "datePublished": "2026-07-23", "dateModified": "2026-07-28", "publisher": { "@type": "Organization", "name": "Cancer Explained", "url": "https://cancerexplained.org" }, "author": { "@type": "Organization", "name": "Cancer Explained Editorial Team" }, "medicalAudience": "Patient", "aspect": "Cancer Information and Support" } </script>
Words to know
Tap any term to see what it means.
Common questions
What should I do if I feel overwhelmed by complex medical terms?
Ask your care team to explain terms in plain language, request written summaries, and bring an advocate to clinic appointments.
Where can I find reliable, verified cancer information?
Rely on established medical sources such as the National Cancer Institute (NCI), ASCO, and CancerExplained.org.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language